< Terug naar vorige pagina
Onderzoeker
Olivier De Wever
- Trefwoorden:Geneeskunde
Affiliaties
- Observerende Klinische wetenschappen (Departement)
Lid
Vanaf1 okt 2017 → Heden - Observerende Klinische wetenschappen (Departement)
Lid
Vanaf1 okt 2017 → 20 okt 2022
Publicaties
1 - 5 van 5
- Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma(2023)
Auteurs: Emiel A De Jaeghere, Sandra Tuyaerts, An Van Nuffel, Ann Belmans, Kris Bogaerts, Regina E. M. Baiden-Amissah, Lien Lippens, Peter Vuylsteke, Stéphanie Henry, xuan bich trinh, et al.
Pagina's: 475-491 - Systemically circulating bacterial extracellular vesicles(2022)
Auteurs: An Hendrix, Olivier De Wever
Pagina's: 213-216 - Heterogeneity of CAFfeinated Tumors(2022)
Auteurs: Olivier De Wever
Pagina's: 537-538 - Targeting USP13 mediated drug tolerance increases the efficacy of EGFR inhibition of mutant EGFR in Non-Small Cell Lung Cancer(2021)
Auteurs: Philippe Giron, Carolien Eggermont, Maxim Noeparast, Hugo Vandenplas, Erik Teugels, Ramses Forsyth, Olivier De Wever, Pedro Aza-Blanc, Gustavo J Gutierrez, Jacques De Grève
Pagina's: 2579-2593 - Targeting Polo-like kinase 1 and TRAIL enhances apoptosis in non-small cell lung cancer(2018)
Auteurs: Alfiah Noor, Ijeoma Umelo, Peter Kronenberger, Philippe Giron, Elly De Vlieghere, Olivier De Wever, Erik Teugels, Jacques De Grève
Pagina's: 28731-28744